Aluma Endovascular Systems

Company Overview

Snapshot

Founded in August 2025 by Ori Kanner, Aluma Endovascular Systems operates with 1–10 employees. The company has completed 2 funding rounds, attracting 1 investor. In October 2025, Peregrine Ventures participated in a Seed funding round.

Business overview

Aluma Endovascular Systems develops advanced laser energy delivery systems that integrate proprietary fiber technology into catheters. This technology is designed to deliver highly localized, high-energy laser pulses to targeted areas, aiming to overcome the power limitations of existing solutions. The company focuses on addressing unmet medical needs for patients with chronic diseases in small arteries, a condition with limited treatment options. Aluma operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Company Intelligence Q&A

When was Aluma Endovascular Systems founded?

Aluma Endovascular Systems was founded in August 2025.

Who is the founder of Aluma Endovascular Systems?

Ori Kanner is the Co-Founder & CEO of Aluma Endovascular Systems.

Which investor participated in Aluma Endovascular Systems' October 2025 funding round?

In October 2025, Peregrine Ventures participated in a Seed funding round for Aluma Endovascular Systems.

What is the primary focus of Aluma Endovascular Systems' technology?

Aluma Endovascular Systems develops advanced laser energy delivery systems with proprietary fiber technology integrated into catheters, designed to deliver localized, high-energy laser pulses for medical applications.

What medical need does Aluma Endovascular Systems aim to address?

Aluma Endovascular Systems aims to address the unmet medical need for treating chronic diseases in small arteries, a condition currently facing limited treatment options and high morbidity and mortality rates.